US 11332438
Creatine prodrugs, compositions and methods of use thereof
granted A61KA61K45/06
Quick answer
US patent 11332438 (Creatine prodrugs, compositions and methods of use thereof) held by Ultragenyx Pharmaceutical Inc. expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K45/06